Ebru Alıcı Davutoğlu

Ebru Alıcı Davutoğlu

Auto-generated profile, based on publicly available information

Ebru Alıcı Davutoğlu

Cerrahpasa Faculty of Medicine, Department of Obstetrics and Gynecology, Istanbul University-Cerrahpaşa, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in European Journal of Radiology
Verified
Journal Article
Closed access
HHHatice Arioz Habibi
Hatice Arioz Habibi
EDEbru Alici Davutoglu
Ebru Alici Davutoglu
SKSedat Giray Kandemirli
Sedat Giray Kandemirli
MAMine Aslan
Mine Aslan
AOAysegul Ozel
Aysegul Ozel
IAIbrahim Adaletli
Ibrahim Adaletli

26 June 2024 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
PDF file
EDEbru Alici Davutoglu
Ebru Alici Davutoglu
GAGorkem Arica
Gorkem Arica
NSNazli Ece Sahin
Nazli Ece Sahin
AUAyse Kalyoncu Ucar
Ayse Kalyoncu Ucar
IAIbrahim Adaletli
Ibrahim Adaletli
RMRiza Madazli
Riza Madazli
Purpose: To assess the incidence of associated structural anomalies, chromosomal/genetic abnormalities, infections, and perinatal outcomes of fetuses with ventriculomegaly (VM), also to evaluate the role of fetal magnetic resonance imaging (MRI) in detecting associated intracranial anomalies. Methods: Retrospective cohort study of 149 prenatally diagnosed pregnancies with fetal VM. VM was classified as mild (Vp = 10–12 mm), moderate (Vp = 12.1–15 mm), and severe (Vp > 15 mm). Fetal MRI was performed to 97 pregnancies. Results: The incidences of an associated CNS, non-CNS, chromosomal anomaly, genetic abnormality and fetal infection were 42.3%, 11.4%, 6.1%, 2.1% and 1.3%, respectively. Fetal MRI identified additional CNS anomalies in 6.7% of cases, particularly in severe VM. The incidences of perinatal outcomes were 18.8% termination of pregnancy, 4% intrauterine and 8.1% neonatal or infant death. The rates of fetuses alive at > 12 months of age with neurological morbidity were 2.6%, 11.1% and 76.9% for mild, moderate and severe isolated VM, respectively. Conclusion: The prognosis of fetuses with VM mostly depends on the severity and the associated anomalies. Mild to moderate isolated VM generally have favorable outcomes. Fetal MRI is particularly valuable in fetuses with isolated severe VM.

30 April 2019 in Düzce Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
AOAysegul Ozel
Aysegul Ozel
SASeda Ateş
Seda Ateş
OŞOsman Şevket
Osman Şevket
MÖMucize Özdemi̇r
Mucize Özdemi̇r
GIGülşah İlHan
Gülşah İlHan
EDEbru Davutoğlu
Ebru Davutoğlu
Aim: The aim of this study was evaluating the effectiveness of vitamin D in the treatment of primary dysmenorrhea.Material and Methods: A total of 142 patients between 16 and 35 years of age who were admitted to a university hospital and diagnosed with primary dysmenorrhea were included in the study in a randomized controlled manner. Cases were randomized into three groups of 667 IU vitamin D once a day, 200 IU vitamin E once a day and 400 mg ibuprofen twice a day. The treatment was given two days before the expected date of menstruation and the first three days of menstruation. Treatment was continued in two consecutive cycles. Severity of menstrual pain was measured with Visual Analogue Scale (VAS), as the primary outcome. Need for using nonsteroidal anti-inflammatory drugs (NSAIDs) during two-month study period was evaluated as the secondary outcome.Results: There were no significant difference in age, body mass index and baseline VAS scores between groups. Pain severity of vitamin D group after treatment was found as low as in the ibuprofen group. Median VAS scores of vitamin D, vitamin E and ibuprofen groups were 5 (1-10), 7 (1-10) and 7 (2-10), respectively after treatment (p<0.001). Requirement of NSAIDs was significantly less in vitamin D group than the vitamin E group (27.3% vs 65.9%, p<0.001). There were no side effects in groups.Conclusion: Both vitamin D and E are effective in alleviation the pain of primary dysmenorrhea, however the effect of vitamin D is clearer.

14 January 2025 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
PDF file
AFAsuman Akkaya Fırat
Asuman Akkaya Fırat
EDEbru Alıcı Davutoğlu
Ebru Alıcı Davutoğlu
AOAysegul Ozel
Aysegul Ozel
STSerap Fırtına Tuncer
Serap Fırtına Tuncer
NYNevin Yılmaz
Nevin Yılmaz
RMRıza Madazlı
Rıza Madazlı
Background: Sirtuins and FoxO1 are reported to be important in the pathophysiology of preeclampsia. This study aimed to investigate whether serum FoxO1 and SIRT2 concentrations differ between preeclampsia and normal pregnancy and also to compare these markers in early- and late-onset preeclampsia. Methods: This cross-sectional study was conducted on 27 women with early-onset preeclampsia, 27 women with late-onset preeclampsia, and 26 healthy normotensive pregnant controls. Maternal serum levels of FoxO1 and SIRT2 were measured with the use of an enzyme-linked immunosorbent assay kit. Results: The mean maternal serum FoxO1 levels were significantly lower both in early-onset (9.1 ± 3.8 vs. 29.1 ± 3.2, p < 0.001) and late-onset preeclampsia (2.6 ± 1.6 vs. 29.1 ± 3.2, p < 0.001) than the normotensive pregnancies. The mean maternal serum FoxO1 level of late-onset preeclampsia was significantly lower than the early-onset preeclampsia group (2.6 ± 1.6 vs. 9.1 ± 3.8, p < 0.001). The mean maternal serum SIRT2 levels were significantly lower both in early-onset (4.5 ± 2.1 vs. 6.3 ± 0.9, p < 0.001) and late-onset preeclampsia (2.1 ± 0.6 vs. 6.3 ± 0.9, p < 0.001) than the healthy pregnancies. Conclusions: FoxO1 and SIRT2 may be biomarkers for early detection of preeclampsia and potential therapeutic targets in the pathophysiology of preeclampsia.

5 December 2022 in Journal of Perinatal Medicine
Verified
Journal Article
Closed access
DKDidem Kaymak
Didem Kaymak
VAVerda Alpay
Verda Alpay
EDEbru Alıcı Davutoğlu
Ebru Alıcı Davutoğlu
MMMelike Makul
Melike Makul
RMRiza Madazlı
Riza Madazlı
Objectives: To develop a nomogram for fetal left brachiocephalic vein (LBCV) diameters during a healthy pregnancy and to assess LBCV values in fetuses with fetal growth restriction (FGR). Methods: This prospective observational study included 31 FGR pregnancies and 438 low-risk pregnancies. The low-risk group was used to determine the 5th, mean, and 95th percentiles for the LBCV between 12 and 39 weeks of gestation based on gestational age. On growth charts, LBCV measurements of FGR fetuses were displayed, and those above the gestational age 95th percentile were considered wide vein. Cerebroplacental ratio (CPR) and umbilical artery (UA), middle cerebral artery (MCA), and ductus venosus (DV) Doppler parameters were evaluated in FGR fetuses. Results: LBCV diameter increased significantly with advancing gestational age. The LBCV diameters were above the 95th percentile in 23 of the 31 FGR fetuses (74.2%). All fetuses (15/15, 100%) with early-onset (EO)-FGR and 8 fetuses (8/16, 50%) with the late-onset (LO)-FGR had LBCV values above the 95th percentile (p<0.01). UA-PI was significantly higher and MCA-PI and CPR were significantly lower in LO-FGR fetuses with LBCV diameters above the 95th percentile (p<0.05). Conclusions: LBCV diameters of fetuses with FGR were significantly wider than the normal population. In the LO-FGR group, there was a good correlation between LBCV diameter and CPR.

3 January 2026 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Open access
PDF file
EDEbru Alici Davutoglu
Ebru Alici Davutoglu
BDBilge Çetinkaya Demir
Bilge Çetinkaya Demir
YDYasemin Doğan
Yasemin Doğan
NSNiyazi Cenk Sayın
Niyazi Cenk Sayın
ODOya Demirci
Oya Demirci
RMRiza Madazli
Riza Madazli
Purpose: To evaluate the incidence of associated structural anomalies, chromosomal/genetic abnormalities, infections and outcomes of fetuses with ventriculomegaly (VM). Methods: Retrospective multicenter cohort study of 627 pregnancies with fetal VM. VM was classified as mild, moderate, or severe and isolated or non‐isolated. Genetic, obstetric and outcome data were collected and compared according to VM categories. Results: The incidences of associated structural anomalies were 21.9%, 53.1% and 63.9% in mild, moderate and severe VM, respectively ( p = 0.032 mild vs. moderate-severe). The incidences of genetic abnormality and fetal infection of the total VM group were 16.1% and 0.8%, respectively, with no significant differences between the VM categories ( p > 0.05). The incidences of pathogenic genetic variant in the mild, moderate and severe VM were 13.5% (5/37), 16.7% (3/18) and 38.1% (8/21), respectively ( p = 0.032 mild vs. severe). Fetal MRI identified additional CNS anomalies in 5.6% of cases. The incidences of surviving babies with neurological morbidities were significantly higher in fetuses with non-isolated VM groups than in isolated VM groups ( p < 0.001). Conclusion: The prognosis of fetuses with VM mostly depends on the severity and the associated anomalies. In all types of fetal VMs additional genetic investigations are valuable.